Navigation Links
ATS Medical Announces Record Quarterly Revenue and Gross Profit
Date:5/5/2008

As announced previously, the Food and Drug Administration (FDA) has

asked ATS to provide additional information and clarification in

support of its PMA for the ATS 3f Aortic Bioprosthesis. The Company

submitted answers to the FDA in March 2008. Management continues to

expect that the ATS 3f Aortic Bioprosthesis will be approved in the

second half of 2008.

-- ATS 3f Enable(TM) Aortic Bioprosthesis: Enrollment continues to

progress with excellent clinical results in the Company's European

clinical trial of its Enable sutureless tissue valve designed to

provide a less invasive approach for aortic valve replacement. The

Company recently implanted the 50th patient in this pivotal trial and

expects to reach enrollment of 100 patients around mid year. The first

regulatory approval for commercialization is expected in mid 2009.

Mechanical Valves

-- ATS Open Pivot AP360(TM) Mechanical Heart Valve: The Company commenced

a limited launch of its ATS AP360 Heart Valve in the first quarter.

The AP360 is the Company's most competitive Open Pivot product, with

the same hemodynamic features as its existing supra annular AP valve

but with a revised cuff design to enable easier suturing. Initial

physician response has been excellent and the company expects to see

measurable revenue growth from this new offering in the second quarter.

Repair Products

-- ATS Simulus(R) Semi-Rigid and Adjustable Flexible Rings: Initial launch

and implants have been completed; surgeon feedback has been very

positive and contributed to revenue growth of 28.0% in the first

quarter of 2008 compared to Q4 2007 and 70.4% compared to the first

quarter of 2007. The ATS Simulus Flexible rings and bands are fast

becoming the annuloplasty device of choice among surgeons performing
'/>"/>

SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Assay Designs(TM) Announces Collaboration with Medical University of South Carolina (MUSC)
2. BioMS Medical announces conference call and web cast for Annual General Meeting
3. Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing
4. National Cancer Registrars Association and IMPAC Medical Systems Announce Best Paper Award Recipients
5. BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008
6. Engineers harness cell phone technology for use in medical imaging
7. Researchers develop method for transmitting medical images via cell phones
8. ATS Medical Announces First Quarter 2008 Earnings Release Date and Conference Call
9. Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30, 2008
10. China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.
11. FDA Clears First Medical Product Made From Yulex(R) Natural Rubber
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014 The report expects global ... by 2019. It also provides a carefully analyzed data ... challenges for the market. , Full Copy of Report ... the global market for cell expansion will keep witnessing ... expects this growth to be driven by rapid technological ...
(Date:12/24/2014)... LOUIS , Dec. 23, 2014 ... today that the waiting period under the Hart-Scott-Rodino ... the acquisition expired on December 22, 2014, thereby ... review requirement for the acquisition of the Company ... U.S. antitrust clearance satisfies another condition to closing ...
(Date:12/22/2014)... RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a ... of autologous cell therapies, announced today the publication of ... conjunction with co-authors from Kyoto University and the University ... clinical research using dermal sheath cup (DSC) cells to ... paper entitled " Hair Follicle Dermal Stem Cells Regenerate ...
(Date:12/22/2014)... ITRA Global, one of the largest organizations ... estate, has further expanded its global reach with the ... Western Australia, reports Mylinda Vick, CCIM, Chairman of the ... / ACORPP (Australian Corporate Property and Projects) , is ... services to a wide range of clients in the ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2
... Oct. 18 /PRNewswire / -- Fate ... human induced pluripotent stem cells (iPSCs) using a combination ... efficiency of reprogramming. The discoveries, which were made ... Fate Therapeutics and The Scripps Research Institute (TSRI), represent ...
... Holdings, Inc. ("Cellu Tissue") today announced that it has filed a ... Commission (the "SEC") relating to a proposed initial public offering of ... shares to be sold by Cellu Tissue and shares to be ... shares to be offered, the allocation of shares to be sold ...
... , BLACKSBURG, Va., Oct. 16 Harold "Skip" Garner ... Institute (VBI) at Virginia Tech. Garner joins VBI from ... he was professor of Biochemistry and Internal Medicine and ... Developmental Biology. Before coming to UTSW in 1994, Garner ...
Cached Biology Technology:Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 2Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 3Cellu Tissue Holdings, Inc. Files Registration Statement for Proposed Initial Public Offering of Common Stock 2Garner to Lead Virginia Bioinformatics Institute 2Garner to Lead Virginia Bioinformatics Institute 3
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... addition of the "iPhone 5S Fingerprint Sensor ... report to their offering. ... acquisition of AuthenTec in July 2012, Apple introduced ... It is currently the only device of Apple ...
(Date:12/17/2014)... 2014 The Defense Logistics Agency is ... detect and prevent counterfeit microcircuits from entering into ... started performing an in-house microcircuit anti-counterfeit initiative dubbed ... of purchased microcircuits while increasing their reliability throughout ... will be conducted at DLA,s Electronics Product Test ...
(Date:12/15/2014)... 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a ... recognition system measures the overall facial feature of ... and the distance between eyes. Facial recognition is ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... selection at the single-gene level have a powerful new ... in molecular and computational biology in the USC College ... sought to replace the standard neutral model, a common ... method based on hard genomic data. , The group's ...
... by scientists at the Broad Institute of MIT and ... extensive library of molecular reagents to silence most human ... 24 issue of Cell, this library consists of small ... the user to dissect the genetic underpinnings of normal ...
... many years debated the cause of the Plague of ... using DNA collected from teeth from an ancient Greek ... responsible for this devastating epidemic. The study appears on ... Diseases (IJID) published by Elsevier on behalf of the ...
Cached Biology News:Natural selection at single gene demonstrated 2New RNAi tools enable systematic studies of gene function 2New RNAi tools enable systematic studies of gene function 3Typhoid fever led to the fall of Athens 2
... known as ChemiArrayTM Mouse Cytokine Antibody ... current methodologies. Besides the ability to ... a more accurate reflection of active ... secreted cytokines, and no amplification step ...
... DNA Engine instrument is the cycler ... Unprecedented thermal uniformity and swappable blocks ... This rugged machine is ... a platform for new features and ...
... (MSTA) slides were designed to study protein expression ... species. Tissue slices from three different species ... then be treated as a single histological slide ... hybridization. This format allows a rapid ...
... Multiple Species Tissue Array (MSTA) slides were designed ... and tissues from multiple species. Tissue slices ... MSTA slide which can then be treated as ... or in situ hybridization. This ...
Biology Products: